Recombinant Antibodies: Covagen AG presents the Fynomer technology

Event date 13 June 2010 – 17 June 2010

Location The Crowne Plaza Berlin City Centre, Germany

Speaker: Dr. Simon Brack, Head of Lead Discovery, Covagen AG, Zürich, Switzerland Topic: Fynomers Neutralizing IL-17A: Making Use of Fc fusion protein We will present the versatility and broad applicability of the Fynomer technology. As an example, the isolation and characterization of high-affinity Fynomers capable of neutralizing IL-17 will be shown. Furthermore, engineered Fynomer-Fc fusion proteins having appropriate physico-chemical and in vivo half-life properties are attractive drug candidates for pre-clinical and clinical development. For more info about the event please visit www.informaglobalevents.com/event/antibodies

Categories

  • biosensor
  • attana
  • qcm
  • attana a200

Related content

  • PEGS 2010 with Attana!

    We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

  • Biotech companies - Ways to work more efficiently

    Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:

Related events